Description

Pendetide is a chelating agent, can be conjugated with Indium (111In) Capromab for further diagnostic use. Capromab pendetide is a FDA-approved imaging agent for the detection of soft tissue metastases in prostate carcinoma[1].—–C31H47N7O14—-[1]Ganesh V Raj, et al. Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy. Cancer. 2002 Feb 15;94(4):987-96.–148805-91-8–741.74—-OC(C=C1)=CC=C1C[C@H](NC(CN)=O)C(N[C@H](C(O)=O)CCCCNC(CN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O)=O)=O–Cancer–10 mM in DMSO–Others—-Others–Peptides